What's breaking now, across thousands of outlets.
(MedPage Today) -- Subcutaneous efgartigimod PH20 (Vyvgart Hytrulo) met the primary endpoint in the phase III ADAPT OCULUS trial of people with ocular myasthenia gravis show, interim data showed. At 4 weeks, ocular myasthenia gravis patients treated...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
The measures come after Darya Shipilova, a lab technician at the Irkutsk Anti-Plague Research Institute in Shelekhov, died after reportedly contracting plague on Oct. 2.
The National Health Insurance Authority has expanded insurance support to cut cancer treatment costs, shielding eligible patients from 80% of medicine cost Read More…
'Overall, we mostly just want to create a space where people can celebrate and feel supported, remember those that they love and maybe have lost, and also provide a space for people living with breast…
The National Health Insurance Authority has expanded insurance support to cut cancer treatment costs, shielding eligible patients from 80% of medicine cost Read More…
*NHIA-Roche initiative cuts cost of selected drugs by 80%, expands support for radiotherapy, diagnostics James Emejo in Abuja The National Health Insurance Authority (NHIA) has urged Nigerian women to…
Dubai: A number of schoolgirls at a secondary school in Kuwait suffered breathing difficulties in an incident that prompted an immediate investigation, the Ministry of Education said, adding that all…
